Should All Reversal Agents be Stocked in Critical Access Hospitals?

VIEW PROGRAM

As the utilization of direct oral anticoagulants (DOACs) increases, there is a parallel increase in major bleeding events, especially intracranial hemorrhages, requiring hospitalization. Clinicians are not recognizing or distinguishing major from minor bleeding or appropriately employing emergent options to manage major bleeding. Recent solutions for DOAC related life-threatening bleeding are under-recognized and under-utilized solutions for patients with these life-threatening emergencies. Over the last 12-18 months, nationally recognized guidelines have provided clear direction on how best to manage these types of major bleeding events. As data emerges regarding new approaches to therapy, clinicians need to be aware of these new and effective approaches and to assess the benefits and risks associated with each of these approaches. Education provided by experts from the EMCREG-International network within this program correctly and promptly address patient treatment approaches to the appropriate healthcare professionals.

This program covers management of life-threatening bleeding of anticoagulated patients and the use of reversal/repletion agents in critical access hospitals.

Should All Reversal Agents be Stocked in Critical Access Hospitals?
John Fanikos, RPh, MBA
Executive Director of Pharmacy Services, Brigham & Women’s Hospital, Boston, MA

Development of a Collaborative Transfer Policy for Referring Hospitals to Care for Anticoagulated Patients with Life-Threatening Bleeding
Joshua M. Kosowsky, MD
Clinical Director- Emergency Medicine, Vice-Chair- Clinical Affairs, Assistant Professor- Harvard Medical School, Brigham & Women’s Hospital, Boston, MA

Case Study: A 74-Year-Old Female on DOAC for Atrial Fibrillation Presenting to a Community Hospital with ICH
Joshua M. Kosowsky, MD

Panel discussion: What Is the Optimal Approach to Caring for the Anticoagulated Patient with Life-Threatening Bleeding in a Critical Access Hospital?
Moderator: W. Brian Gibler, MD FACEP, FACC, FAHA
President, EMCREG-International, Professor of Emergency Medicine, Director of Business Development, Department of Emergency Medicine, University of Cincinnati College of Medicine, Cincinnati, OH